Article
Early economic modelling of a new pharmacotherapeutic treatment pathway for children with monogenic obesity
2026-05-17
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> Early onset obesity in children, almost always accompanied by significant health complications, may be driven by rare genetic variants that influence appetite, metabolism, and nutrient absorption. Traditional treatment approaches are usually insufficient for those with monogenic obesity of this type. Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide, and...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2f669915-beea-5509-94d0-28cb29e3daa9
- DOI
- 10.64898/2026.05.13.26353098
